Health authorities have confirmed a case of circulating vaccine-derived poliovirus type 1 (PVDVC1) in Algeria, marking a new outbreak as of September 17, 2025.⁤ The case involves paralysis ‍that began on January 25, 2025, in El Tarf province.

Further investigation revealed a genetically linked PVDVC1 strain in ⁣an environmental sample collected on March 17, 2025, in Oran. This environmental detection confirms ongoing virus circulation and suggests a wider geographic spread than initially identified.

Circulating vaccine-derived poliovirus emerges in areas wiht low immunization coverage. ⁤The virus can than mutate and regain the⁣ ability⁣ to cause paralysis, similar to⁣ wild poliovirus. Travel ⁢Health Pro ⁢provides ongoing updates on ⁢global outbreaks and⁣ health risks.

traveler Considerations: ⁢ While Algeria ⁤has made significant strides in polio eradication, this ⁢re-emergence underscores the importance of vaccination. Travelers to Algeria should ensure they are⁤ fully‍ vaccinated against ⁣polio, and consult with a healthcare professional regarding any potential ⁢risks or necessary precautions.

Geographic Impact: The current outbreak⁢ is ⁣concentrated‍ in Algeria, but‍ ongoing surveillance is crucial to prevent further‍ spread within the country⁤ and internationally.